Back
Investors Title Vs. Denali Therapeutics Industry Stock Comparison
Buy
70
ITIC
Investors Title
Last Price:
228.99
Seasonality Move:
5.01%
Buy
56
DNLI
Denali Therapeutics
Last Price:
30.94
Seasonality Move:
17.79%
Buy
70
Investors Title (ITIC)
is a Buy
Is Investors Title a Buy, Sell or Hold?
- The current Investors Title [ITIC] share price is $233.63. The Score for ITIC is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- ITIC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $31.08. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ITIC Stock Price Chart
What is Investors Title's stock price today?
-
The Investors Title share price today is $233.63
The current trend is moderately bullish and ITIC is experiencing selling pressure, which indicates risk of future bearish movement.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $31.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
ITIC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.61 | Buy |
Relative Strength Index (14 RSI): | 65.21 | Buy |
Chaikin Money Flow: | -11281 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (218.9 - 228.18) | Buy |
Bollinger Bands (100): | (166.55 - 214.53) | Buy |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.89 | Buy |
Relative Strength Index (14 RSI): | 78.97 | Buy |
Chaikin Money Flow: | -360034 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.61 - 28.65) | Buy |
Bollinger Bands (100): | (19.18 - 25.48) | Buy |
ITIC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 227.91 | Buy |
20-day SMA: | 224.79 | Buy |
50-day SMA: | 211.66 | Buy |
200-day SMA: | 175.05 | Buy |
8-day EMA: | 229.01 | Buy |
20-day EMA: | 224.14 | Buy |
50-day EMA: | 212.04 | Buy |
200-day EMA: | 181.87 | Buy |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.38 | Buy |
20-day SMA: | 26.7 | Buy |
50-day SMA: | 24.56 | Buy |
200-day SMA: | 20.65 | Buy |
8-day EMA: | 29.49 | Buy |
20-day EMA: | 27.36 | Buy |
50-day EMA: | 25.05 | Buy |
200-day EMA: | 22.29 | Buy |
Investors Title Earnings Growth & ITIC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Investors Title Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |